2021 LUNGevity Early Detection Award

LUNGevity’s Early Detection Award for Lung Cancer Translational Research program supports the development of strategies for the early detection and/or diagnosis of lung cancer.

Applicants must:

  • Hold a doctoral degree and faculty appointment with an academic institution, including research institutions that are not formally associated with a university
  • Have completed a training fellowship

The project that will be funded in 2021 is expected to have a direct impact on the early detection and/or diagnosis of lung cancer or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or diagnosis of lung cancer.

The Early Detection Award may be for a maximum of $200,000-$300,000 per year over two years. Annual milestones must be met.

LUNGevity uses a two-step application process:

  1. A letter of intent (LOI), with a brief overview of the proposed project and biographical information
  2. A full application with an extended narrative about the project, as well as supporting information and documentation. (Because there are a limited number of awards, only a subset of applicants is invited to submit a full application after the LOI review is completed.)

Reviewers are drawn from our Scientific Advisory Board and other lung cancer experts. Awardees have progress and financial reporting obligations during their award term.

A complete description, terms and conditions, and instructions are included in the 2021 LUNGevity Early Detection Award RFA.  All application materials must be submitted electronically via proposalCENTRAL.

2021 Early Detection Award Timeline

LOIs due: by February 24, 2021, 11:59 pm EST
Full application invitations: No earlier than April 1, 2021
Full application due (by invitation only): May 10, 2021, 11:59 pm EDT
Award announcement: Late summer 2021
Anticipated year-one funding: November 2021

 

print